Mirae Asset Global Etfs Holdings Ltd. Ionis Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 7,825 shares of IONS stock, worth $284,282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,825
Previous 6,357
23.09%
Holding current value
$284,282
Previous $302,000
3.64%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$547 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$515 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$375 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$317 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$286 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.16B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...